DE69231274D1 - Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist - Google Patents
Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonistInfo
- Publication number
- DE69231274D1 DE69231274D1 DE69231274T DE69231274T DE69231274D1 DE 69231274 D1 DE69231274 D1 DE 69231274D1 DE 69231274 T DE69231274 T DE 69231274T DE 69231274 T DE69231274 T DE 69231274T DE 69231274 D1 DE69231274 D1 DE 69231274D1
- Authority
- DE
- Germany
- Prior art keywords
- modulating
- receptor antagonist
- opiate receptor
- hyperkinetic
- disording
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66054391A | 1991-02-25 | 1991-02-25 | |
PCT/US1992/001418 WO1992014364A1 (en) | 1991-02-25 | 1992-02-25 | Opiate receptor antagonist modulates hyperkinetic movement disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231274D1 true DE69231274D1 (de) | 2000-08-24 |
DE69231274T2 DE69231274T2 (de) | 2000-11-30 |
Family
ID=24649948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231274T Expired - Fee Related DE69231274T2 (de) | 1991-02-25 | 1992-02-25 | Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist |
Country Status (9)
Country | Link |
---|---|
US (1) | US6153620A (de) |
EP (1) | EP0573565B1 (de) |
JP (1) | JPH06505747A (de) |
AT (1) | ATE194753T1 (de) |
AU (1) | AU658401B2 (de) |
CA (1) | CA2104229C (de) |
DE (1) | DE69231274T2 (de) |
ES (1) | ES2148174T3 (de) |
WO (1) | WO1992014364A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9815618D0 (en) | 1998-07-18 | 1998-09-16 | Univ Manchester | Treatment of dyskinesia |
DK2368554T3 (en) | 2003-04-08 | 2015-01-26 | Progenics Pharm Inc | A pharmaceutical composition comprising methylnaltrexone |
MX2007010833A (es) | 2005-03-07 | 2009-02-17 | Univ Chicago | Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales. |
US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
CA2865661C (en) | 2007-03-29 | 2016-05-17 | Progenics Pharmaceuticals, Inc. | Peripheral opioid receptor antagonists and uses thereof |
CN101801979A (zh) | 2007-03-29 | 2010-08-11 | 普罗热尼奇制药公司 | (r)-n-溴化甲基纳曲酮的晶体形式及其用途 |
SI2565195T1 (sl) | 2007-03-29 | 2015-09-30 | Wyeth Llc | Periferalni opioidni receptorji in antagonisti in njih uporaba |
CA2685126C (en) * | 2007-04-24 | 2015-04-14 | Toray Industries, Inc. | Therapeutic or prophylactic agent for dyskinesia |
US20100216857A1 (en) * | 2007-10-18 | 2010-08-26 | Luhrs Lauren M B | Method of treating motor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione |
JP5358587B2 (ja) | 2008-02-06 | 2013-12-04 | プロジェニックス・ファーマシューティカルス・インコーポレイテッド | (r),(r)−2,2’−ビス−メチルナルトレキソンの製造及び用途 |
CA2719134C (en) | 2008-03-21 | 2015-06-30 | The University Of Chicago | Treatment with opioid antagonists and mtor inhibitors |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
GB2543271A (en) * | 2015-10-12 | 2017-04-19 | Lars Holger Hermann Dr | Products for treating psychogenic pain disorders |
-
1992
- 1992-02-25 WO PCT/US1992/001418 patent/WO1992014364A1/en active IP Right Grant
- 1992-02-25 DE DE69231274T patent/DE69231274T2/de not_active Expired - Fee Related
- 1992-02-25 CA CA002104229A patent/CA2104229C/en not_active Expired - Fee Related
- 1992-02-25 AT AT92907704T patent/ATE194753T1/de not_active IP Right Cessation
- 1992-02-25 JP JP4507357A patent/JPH06505747A/ja active Pending
- 1992-02-25 EP EP92907704A patent/EP0573565B1/de not_active Expired - Lifetime
- 1992-02-25 AU AU14563/92A patent/AU658401B2/en not_active Ceased
- 1992-02-25 ES ES92907704T patent/ES2148174T3/es not_active Expired - Lifetime
-
1993
- 1993-01-21 US US08/006,691 patent/US6153620A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0573565B1 (de) | 2000-07-19 |
ES2148174T3 (es) | 2000-10-16 |
CA2104229A1 (en) | 1992-08-26 |
AU658401B2 (en) | 1995-04-13 |
EP0573565A1 (de) | 1993-12-15 |
EP0573565A4 (de) | 1994-03-18 |
AU1456392A (en) | 1992-09-15 |
WO1992014364A1 (en) | 1992-09-03 |
JPH06505747A (ja) | 1994-06-30 |
ATE194753T1 (de) | 2000-08-15 |
US6153620A (en) | 2000-11-28 |
CA2104229C (en) | 1997-04-15 |
DE69231274T2 (de) | 2000-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231274T2 (de) | Hyperkinetische bewegungsstörung modulierender opiatrezeptor-antagonist | |
MY107158A (en) | 3-arylcarbonyl; -1h-indoles useful as therapeutic agents. | |
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
ATE279517T1 (de) | Il-17 receptor | |
NO305603B1 (no) | 2,6-diaminopurin-derivater, anvendelse derav samt farmas°ytisk blanding | |
DE68922176D1 (de) | Doppelblick-Arthroskop. | |
DZ1763A1 (fr) | Composition vaccinantes. | |
OA09912A (en) | Fungicides. | |
NO960630L (no) | Heterocykler anvendelige som neurokinin antagonister | |
EA200100022A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
AU2793992A (en) | Tricyclic quinoxalinediones as glutamate receptor antagonists | |
NO994136D0 (no) | Faktor X delesjonsmutanter samt analoger derav | |
EA199700160A1 (ru) | Производные индола в качестве антагонистов eaa | |
NO973099D0 (no) | Fôring of formet ladning, spesielt for bruk i en brönnperforeringskanon | |
NO932377L (no) | Antivirale forbindelser | |
EP0714295A4 (de) | ||
DE69201906D1 (de) | Zylinderbüchse. | |
ATE227122T1 (de) | Stabilisierte tablettenformulierung | |
ZA916918B (en) | Amino acid analogs as CCK antagonists. | |
DE69202890D1 (de) | Zylinderlaufbüchse. | |
EP0344979A3 (de) | Alpha-adrenergische Rezeptorantagonisten | |
HU9400417D0 (en) | New leukotriene-b4 antagonists, methods for producing them and their use as drugs | |
GB2269747B (en) | Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists | |
FR2661259B1 (fr) | Systeme de presentation d'images stereoscopiques par projection sur ecran lenticulaire. | |
TW343973B (en) | Morphinan derivative and medical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |